Prescription Drug Inflation Slowing, CMS Studies Show

AUGUST 01, 2005
Prescription Drug Inflation Slowing, CMS Studies Show

The rising cost of prescription drug therapy—a key factor in overall health care inflation for the past decade—has begun to moderate.

New figures issued by the government's Centers for Medicare and Medicaid Services (CMS) indicate that total US spending on prescription medicines rose 10.7% in 2003, a significantly slower rate of increase than the 14.9% jump that occurred in 2002.

Health care analysts contend that this moderating trend has continued into 2005, thanks to a variety of factors including increased consumer acceptance of generic drugs, cost-containment efforts by pharmacy benefit managers, and the withdrawal of several high-priced prescription painkillers such as Vioxx and Bextra.

Mr. Rankin is a freelance medical writer.



SHARE THIS SHARE THIS
0

Immunization Laws Around the Nation

Many areas of medicine that intersect with law and immunizations are associated with a very specific set of laws across the nation.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.